Daytona Beach
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
7- Dermatology
- 3
- Plastic Surgery
- 4
How aesthetic practices structure vendor evaluation
Medspas, dermatology practices, and plastic surgery practices generally route a new biologics vendor through whoever is already responsible for other injectable or topical product sourcing: a practice manager or supervising physician reviews supplier documentation before any purchasing conversation about pricing.
Because these products are supplied for use at the discretion of a licensed physician, the review typically focuses on paperwork, including the certificate of analysis, donor eligibility summary, and lot release record, rather than marketing claims.
Shipping, storage, and record-keeping
Cryopreserved Wharton's jelly and exosome products ship overnight on dry ice in validated containers and need to move into -80 degree C storage soon after arrival; practices in the Southeast should schedule orders for days with staff coverage to receive them. Lyophilized formats are shelf-stable under normal storage conditions and are reconstituted according to the insert provided with each lot.
Clinics are expected to track product use by lot at the patient record level, which supports traceability back to the donor lot if a question about a specific shipment ever arises.
Physician supervision and account verification
Because medspas often operate under a supervising physician who may not be the person placing orders, Precision Biologics ties each account to an NPI and confirms that NPI against the NPPES registry before activating pricing access. The practice itself remains responsible for confirming its supervising physician's standing with the Florida Board of Medicine and for consulting its own counsel on how any product fits its regulatory posture.
Account setup with Precision Biologics includes NPI verification followed by release of the standard documentation set, so a practice's internal review can proceed without placing an order first.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Can a medspa order directly, or does the account need to be in the supervising physician's name?+
Accounts are tied to an NPI, which in many medspa arrangements belongs to the supervising physician. The practice should set up the account under whichever NPI reflects its supervisory structure.
Do Precision Biologics documents mention specific uses or protocols for aesthetic practices?+
No. Documentation covers donor eligibility, processing, and lot testing. Decisions about clinical use are the responsibility of the licensed physician and the practice's own counsel.
How many aesthetic providers does the Daytona Beach NPPES count actually represent?+
The October 27, 2026 registry count is 7 individual providers across Dermatology and Plastic Surgery taxonomies in Daytona Beach specifically. It excludes medspas without their own NPI listing and providers in nearby metro cities, so it understates the full local market.